Evidence map›Paper›PMID 33358557›Full record

ArticleThe Journal of allergy and clinical immunology2021

Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2.

Terrie S Ahn, Brandon Han, Paul Krogstad, Chantana Bun, Lisa A Kohn, Maria I Garcia-Lloret, Robert Damoiseaux, Manish J Butte

Abstract readLetter
In one paragraph

Article in The Journal of allergy and clinical immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Terrie S AhnDivision of Immunology, Allergy, and Rheumatology, Department of Pediatrics, University of California Los Angeles, Los Angeles, Calif.
Brandon HanDepartment of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, Calif; California NanoSystems Institute, University of California Los Angeles, Los Angeles, Calif.
Paul KrogstadDepartment of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, Calif; Division of Infectious Diseases, Department of Pediatrics, University of California Los Angeles, Los Angeles, Calif.
Chantana BunDivision of Immunology, Allergy, and Rheumatology, Department of Pediatrics, University of California Los Angeles, Los Angeles, Calif.
Lisa A KohnDivision of Immunology, Allergy, and Rheumatology, Department of Pediatrics, University of California Los Angeles, Los Angeles, Calif.
Maria I Garcia-LloretDivision of Immunology, Allergy, and Rheumatology, Department of Pediatrics, University of California Los Angeles, Los Angeles, Calif.
Robert DamoiseauxDepartment of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, Calif; California NanoSystems Institute, University of California Los Angeles, Los Angeles, Calif; Department of Bioengineering, Samueli School of Engineering, University of California Los Angeles, Los Angeles, Calif.
Manish J ButteDivision of Immunology, Allergy, and Rheumatology, Department of Pediatrics, University of California Los Angeles, Los Angeles, Calif; Department of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles, Los Angeles, Calif. Electronic address: mbutte@mednet.ucla.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, NeutralizingAntibodies, ViralCOVID-19Cross ReactionsHumansSARS-CoV-2Spike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID33358557
PMCPMC7833834

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.